Статья

Transfer and loss of allergen-specific responses via stem cell transplantation: A prospective observational study

M. Debiasi, H. Pichler, F. Klinglmüller, H. Boztug, K. Schmidthaler, J. Rech, D. Scherer, C. Lupinek, R. Valenta, E. Kacinska-Pfaller, R. Geyeregger, G. Fritsch, O. Haas, C. Peters, T. Lion, M. Akdis, S. Matthes, C. Akdis, Z. Szépfalusi, T. Eiwegger,
2020

Background: Currently, no estimates can be made on the impact of hematopoietic stem cell transplantation on allergy transfer or cure of the disease. By using component-resolved diagnosis, we prospectively investigated 50 donor-recipient pairs undergoing allogeneic stem cell transplantation. This allowed calculating the rate of transfer or maintenance of allergen-specific responses in the context of stem cell transplantation. Methods: Allergen-specific IgE and IgG to 156 allergens was measured pretransplantation in 50 donors and recipients and at 6, 12 and 24 months in recipients post-transplantation by allergen microarray. Based on a mixed effects model, we determined risks of transfer of allergen-specific IgE or IgG responses 24 months post-transplantation. Results: After undergoing stem cell transplantation, 94% of allergen-specific IgE responses were lost. Two years post-transplantation, recipients' allergen-specific IgE was significantly linked to the pretransplantation donor or recipient status. The estimated risk to transfer and maintain individual IgE responses to allergens by stem cell transplantation was 1.7% and 2.3%, respectively. Allergen-specific IgG, which served as a surrogate marker of maintaining protective IgG responses, was highly associated with the donor's (31.6%) or the recipient's (28%) pretransplantation response. Conclusion: Hematopoietic stem cell transplantation profoundly reduces allergen-specific IgE responses but also comes with a considerable risk to transfer allergen-specific immune responses. These findings facilitate clinical decision-making regarding allergic diseases in the context of hematopoietic stem cell transplantation. In addition, it provides prospective data to estimate the risk of transmitting allergen-specific responses via hematopoietic stem cell transplantation.

Цитирование

Похожие публикации

Источник

Версии

  • 1. Version of Record от 2020-09-01

Метаданные

Об авторах
  • M. Debiasi
    Medizinische Universitat Wien
  • H. Pichler
    Medizinische Universitat Wien
  • F. Klinglmüller
    Medizinische Universitat Wien
  • H. Boztug
    Medizinische Universitat Wien
  • K. Schmidthaler
    Medizinische Universitat Wien
  • J. Rech
    Medizinische Universitat Wien
  • D. Scherer
    Medizinische Universitat Wien
  • C. Lupinek
    Medizinische Universitat Wien, Zentrum für Pathophysiologie, Infektiologie und Immunologie
  • R. Valenta
    Medizinische Universitat Wien, Zentrum für Pathophysiologie, Infektiologie und Immunologie, State Research Center Institute of Immunology FMBA
  • E. Kacinska-Pfaller
    Medizinische Universitat Wien
  • R. Geyeregger
    Children's Cancer Research Institute, Vienna
  • G. Fritsch
    Children's Cancer Research Institute, Vienna
  • O. Haas
    Medizinische Universitat Wien, Children's Cancer Research Institute, Vienna
  • C. Peters
    Medizinische Universitat Wien
  • T. Lion
    Medizinische Universitat Wien, Children's Cancer Research Institute, Vienna
  • M. Akdis
    University of Zurich, Christine Kühne-Center for Allergy Research and Education
  • S. Matthes
    Medizinische Universitat Wien
  • C. Akdis
    University of Zurich, Christine Kühne-Center for Allergy Research and Education
  • Z. Szépfalusi
    Medizinische Universitat Wien
  • T. Eiwegger
    Medizinische Universitat Wien, Hospital for Sick Children University of Toronto, Hospital for Sick Children University of Toronto, University of Toronto
Название журнала
  • Allergy: European Journal of Allergy and Clinical Immunology
Том
  • 75
Выпуск
  • 9
Страницы
  • 2243-2253
Финансирующая организация
  • Austrian Science Fund
Номер гранта
  • F4605
Тип документа
  • journal article
Тип лицензии Creative Commons
  • CC BY
Правовой статус документа
  • Свободная лицензия
Источник
  • scopus